China Resources Medical Holdings Co., Ltd.

China Resources Medical Holdings Co., Ltd.

0.28
EUR
0.00
(0.00%)
457.93MMarket Cap
Mar 30Next Earn
China Resources Medical Holdings Co., Ltd.
MUN:1PH
(Munich Stock Exchange)

Recent

price

0.28

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.91
1.54
1.45
1.68
1.7
1.47
1.63
1.69
2.19
3.54
6.26
7.99
7.79
7.26
- -
Revenue per Share
0.12
0.16
0.28
0.2
-1.67
0.33
0.34
0.31
0.25
0.33
0.21
0.2
0.45
0.39
- -
Basic EPS, GAAP
0.17
0.26
0.29
0.24
0.2
0.33
0.22
0.26
0.34
0.38
0.31
0.56
0.56
0.67
- -
Free Cash Flow per Basic Share
- -
- -
0.05
0.04
0.09
0.05
0.09
0.1
0.09
0.07
0.1
0.03
0.11
0.13
- -
Dividend per Share
0.58
1.94
1.95
2.1
4.04
4.23
4.31
4.55
4.71
4.97
7.33
4.6
4.91
5.18
5.18
Book Value per Share
- -
1.37
1.34
1.43
1.16
1.36
1.46
1.85
2.54
3.16
4.39
1.71
2.06
2.33
2.33
Tangible Book Value per Share
834
576
831
819
902
1,278
1,267
1,253
1,256
1,256
1,262
1,264
1,264
1,264
1,264
Basic Weighted Avg Shares
758
887
1,206
1,372
1,533
1,878
2,059
2,115
2,751
4,447
7,901
10,108
9,855
9,176
- -
Sales/Revenue/Turnover
17.81
15.67
17.66
13.09
15.31
24.32
25.89
24.05
10.99
10.08
6.41
9.53
7.86
5.04
- -
Operating Margin (%)
36
37
39
45
51
67
73
64
113
183
486
611
619
585
- -
Depreciation Expense
101
90
230
167
-1,507
421
431
391
310
418
266
258
566
496
- -
Net Income, GAAP
24.81
32.77
24.38
30.47
- -
23.2
25.37
25.99
23.4
- -
22.38
33.48
19.9
25.62
- -
Effective Tax Rate (%)
13.34
10.14
19.07
12.17
-98.31
22.42
20.92
18.48
11.27
9.4
3.36
2.55
5.74
5.41
- -
Profit Margin (%)
163
1,071
1,019
904
902
1,137
1,256
1,814
1,940
481
1,642
-1,778
-1,260
-1,577
-1,577
Working Capital
232
- -
- -
- -
- -
- -
- -
14
47
40
1,053
988
842
145
145
LT Debt
578
1,716
1,735
1,863
5,358
5,602
5,710
6,140
6,340
6,846
10,654
7,013
7,498
7,888
7,888
Total Equity
- -
6.59
9.23
6.82
- -
6.44
6.52
5.72
3.17
- -
2.78
2.87
6.6
5.61
- -
Return on Invested Capital (%)
- -
7.87
12.12
8.99
- -
7.41
7.11
6.08
4.53
- -
2.28
2.36
5.53
5.15
- -
Return on Capital (%)
- -
8.56
14.18
9.9
-43.14
7.86
7.78
6.8
5.16
6.66
3.33
3.36
9.41
7.77
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
754
910
708
LT Borrowings
735
- -
- -
LT Finance Leases
107
115
145
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,264
1,264
1,264
Market Capitalization
- -
4,740
3,762

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
3,239
3,514
2,853
Cash, Cash Equivalents & STI
977
1,245
940
Accounts Receivable, Net
1,412
1,611
1,243
Inventories
302
301
262
Total Current Liabilities
4,499
4,725
4,430
Payables & Accruals
- -
- -
- -
ST Debt
754
910
708
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.64%
8.31%
5.2%
Free Cash Flow
23.2%
18.63%
19.51%
Net Income, GAAP
-105.52%
20.51%
-12.36%
Sales/Revenue/Turnover
23.45%
31.58%
-6.89%
Total Cash Common Dividend
41.04%
40.51%
19.95%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
10,108
2024
- -
- -
9,855
2025
- -
- -
9,176

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.2
2024
- -
- -
0.45
2025
- -
- -
0.39

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.03
2024
- -
- -
0.11
2025
- -
- -
0.13
Business
China Resources Medical Holdings Company Limited operates as an integrated medical and healthcare service provider primarily in China. The company’s core offerings include hospital investment, management, and operation; clinical diagnosis and treatment; healthcare management; and public health services. It manages a comprehensive network of medical institutions comprising general hospitals, specialized hospitals, community health centers, and clinics across major regions including Beijing, North China, East China, Central China, and South China. Its medical facilities include service levels from tertiary to primary care with over 10,000 open beds and annual outpatient and emergency visits exceeding 7.7 million. The company specializes in multi-level healthcare services such as clinical treatment, healthcare management, public health services, and related medical support operations. Recent major developments include significant expansion through acquisition and integration strategies. In 2022, China Resources Medical enhanced its medical service capacity by acquiring 33 high-quality medical institutions, increasing open beds by more than 11,000 and boosting overall service and profit contribution. In August 2024, it entered into strategic cooperation and acquisition agreements with Tasly Pharmaceuticals aiming at innovation in digital traditional Chinese medicine, intelligent manufacturing, R&D, and expanding its industrial investment footprint notably in Tianjin. The company’s growth strategy integrates merger and acquisition activity with capital infusion to strengthen its operational network and service capacities. Additionally, China Resources Medical continues to benefit from its backing by China Resources Group, a major state-owned conglomerate. Founded in 1999 and headquartered in Hong Kong, China Resources Medical Holdings Company Limited leverages its extensive hospital network and healthcare ecosystem across mainland China to offer comprehensive medical services. It is listed on the Hong Kong Stock Exchange under the ticker 1515.HK. The company is positioned in the healthcare industry, targeting broad patient populations and healthcare needs in urban and regional markets. Its expanding portfolio aligns with national healthcare reform trends and rising demand for integrated medical services in China. China Resources Medical thus operates with a strong emphasis on hospital management and healthcare service integration, supported by strategic acquisitions, partnerships in pharmaceutical innovation, and continuous enhancement of healthcare infrastructure and service quality across China.